Research finds no correlation between regulatory T cells and survival in glioblastoma

April 16, 2015, The Geisel School of Medicine at Dartmouth

Using a novel methodology of epigenetic quantitative analysis, Dartmouth-Hitchcock's Norris Cotton Cancer Center's interdisciplinary team of investigators led by Camilo Fadul, MD, found no correlation between regulatory T cells (Tregs) and survival in the tumor microenvironment or blood, even when adjusting for well-known prognostic factors. Titled, "Regulatory T Cells Are Not a Strong Predictor of Survival for Patients with Glioblastoma," the findings were published in Neuro-Oncology.

"The traditional methods to quantify Tregs may be subjective and result in variability that may explain, in part, the controversial results found in the past," said Fadul. "We used epigenetic , a novel methodology that more accurately measures lymphocyte populations including Tregs in tumor tissue and peripheral blood."

Patients with glioblastoma, the most frequent and malignant type of brain cancer, exhibit tumor induced . Regulatory T are one of the types of cells in charge of controlling the immune system in the healthy recognition of self (tolerance) and non-self (foreign) antigens. Patients with glioblastoma have a higher proportion of Tregs than healthy controls, but how important the Tregs are in suppressing the immune system, and if that correlates with prognosis, has been controversial.

Fadul's team studied the correlation with survival, of the Tregs in the as well as in peripheral blood of 25 patients with newly diagnosed glioblastoma. They examined tumor-infiltrating Tregs and CD3+ T cells using quantitative DNA demethylation analysis (epigenetic qPCR) and by immunohistochemistry, and peripheral blood Treg proportions measured by flow cytometry. Further analysis used data from The Cancer Genome Atlas to correlate expression of Treg markers with patient survival and glioblastoma subtypes.

"Our finding of no correlation between Tregs and survival in glioblastoma has implications for the design of future immune therapy clinical trials," said Fadul.

The Dartmouth investigators hypothesize that an immune "net score," which takes into account the proportion of regulatory and effector immune cells as well as the expression of co-stimulatory and inhibitory receptors by both cancer and immune cells, will be a useful indicator of the patient's immune status with prognostic and therapeutic implications.

Looking forward, Fadul is analyzing 100 glioblastoma samples from another medical center and using the same novel methodology to determine a model that may allow neuro-oncologists to prognosticate and personalize the therapy approach.

Explore further: Team discovers mechanism responsible for tumor invasion in brain cancer

More information: Neuro Oncol (2015). DOI: 10.1093/neuonc/nou363

Related Stories

Team discovers mechanism responsible for tumor invasion in brain cancer

April 9, 2015
A neuro-oncology research team at Dartmouth's Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of ...

T cell receptor ensures Treg functionality

January 8, 2015
Misdirected immune responses that target the body's own tissue can result in diseases. regulatory T cells combat this effect by suppressing excessive immune responses and responses against our own bodies. Until now, scientists ...

Itch maintains regulatory T cell stability

October 26, 2013
Regulatory T cells (Tregs) function to suppress immune responses of other cells, and their dysfunction has been associated with development of immune disorders. Recent studies suggest that Tregs maintain plasticity even after ...

Researchers find importance of regulatory T-cells generated early in life

March 31, 2015
(MedicalXpress)—Originating in the thymus, the autoimmune regulator (Aire) protein controls a key mechanism that prevents the immune system from attacking the body itself. Individual T cells attack different substances; ...

Balancing T cell populations

November 25, 2013
Depending on the signals received, naïve T cells are able to differentiate into mature T cell populations, which play different roles in the immune system. For example, regulatory T cells (Tregs) are important for tamping ...

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.